From Cambridge, UK: PlaqueTec has a unique liquid biopsy system and multi omic analysis approach that aims to profile the underlying biology of atherosclerosis
- Jun 9
- 1 min read
General Manager Simon Williams describes how the liquid biopsy works and what PlaqueTec is doing in its analysis of the samples. The company is current in an approximately 300 person clinical trial that will finish up towards the end of next year.










.png)